Search - tctmd.com

Displaying 801 - 820 of 970

Sort: Relevancy | Date

Presentation

Long-term Outcome After Drug-Eluting vs. Bare-Metal Stent Implantation in Patients with STEMI

Presenter: L. Holmvang

June 24, 2013

Presentation

Clinical Outcomes with Drug-Eluting and Bare-Metal Stents in Patients with STEMI

Presenter: T. Palmerini

June 04, 2013

News Conference News EuroPCR 2013

COMFORTABLE-AMI: Biodegradable-Polymer DES Offers Lasting Benefit to STEMI Patients

Caitlin E. Cox

May 23, 2013

News Conference News EuroPCR 2013

PRAGUE-19 Registry: Bioresorbable Scaffolds an Option for Certain STEMI Patients

Caitlin E. Cox

May 22, 2013

News Daily News

Prasugrel Noninferior to Ticagrelor in STEMI, but Both Require Hours to Achieve Effect

Yael L. Maxwell

May 13, 2013

News Daily News

Prasugrel No es Inferior al Ticagrelor en los cuadros de STEMI, aunque Deben pasar Horas hasta que Ambos Hagan Efecto

Yael L. Maxwell

May 13, 2013

News Daily News

Los ACV tras un cuadro de STEMI son Raros pero tienen Mal Pronóstico

Yael L. Maxwell

May 03, 2013

News Daily News

Stroke After STEMI Unusual But Carries Poor Prognosis

Yael L. Maxwell

May 03, 2013

News Daily News

Los GPI son Superiores al Tratamientos de Rescate tras una Embolización Endovascular con Espirales contra Aneurismas Cerebrales

Caitlin E. Cox

May 03, 2013

News Daily News

GPIs Superior for Rescue Treatment after Endovascular Coiling for Cerebral Aneurysm

Caitlin E. Cox

May 03, 2013

News Daily News

La Bivalirudina Mejora a la Heprina en la Reducción del Riesgo Hemorrágico tras la CAS

L.A. McKeown

April 26, 2013

News Daily News

Bivalirudin Bests Heparin for Lowering Bleeding Risk After CAS

L.A. McKeown

April 26, 2013

News Daily News

Vorapaxar Substudy Shows Broad MI Reduction in High-Risk ACS Patients

L.A. McKeown

April 19, 2013

News Daily News

Un Subestudio del Vorapaxar revela un Amplio Descenso de IM en Pacientes SCA de Alto Riesgo

L.A. McKeown

April 19, 2013

News Daily News

Rivaroxaban Added to Dual Antiplatelet Therapy Cuts Stent Thrombosis in ACS Patients

Caitlin E. Cox

April 19, 2013

News Daily News

Rivaroxaban + Terapia Antiplaquetaria Doble Reducen la Trombosis del Stent en Pacientes víctimas de un SCA

Caitlin E. Cox

April 19, 2013

Presentation

Reduction of Stent Thrombosis in ACS Patients Treated with Rivaroxaban in ATLAS ACS 2-TIMI 51

Presenter: C. Michael Gibson

April 17, 2013

News Daily News

SCAAR Turns 20: PCI Expanded to Higher-Risk Patients with No Mortality Trade-off

March 25, 2013

News Daily News

SCAAR Cumple 20 Años: PCI Ampliada a Pacientes de Mayor Rieso sin Compensación de Mortalidad

March 25, 2013

News Conference News ACC 2013

STREAM: Fibrinolysis Strategy Effective for STEMI Patients Far From PCI Hospital

Yael L. Maxwell

March 09, 2013

Advertisement

Long-term Outcome After Drug-Eluting vs. Bare-Metal Stent Implantation in Patients with STEMI

Clinical Outcomes with Drug-Eluting and Bare-Metal Stents in Patients with STEMI

COMFORTABLE-AMI: Biodegradable-Polymer DES Offers Lasting Benefit to STEMI Patients

PRAGUE-19 Registry: Bioresorbable Scaffolds an Option for Certain STEMI Patients

Prasugrel Noninferior to Ticagrelor in STEMI, but Both Require Hours to Achieve Effect

Prasugrel No es Inferior al Ticagrelor en los cuadros de STEMI, aunque Deben pasar Horas hasta que Ambos Hagan Efecto

Los ACV tras un cuadro de STEMI son Raros pero tienen Mal Pronóstico

Stroke After STEMI Unusual But Carries Poor Prognosis

Los GPI son Superiores al Tratamientos de Rescate tras una Embolización Endovascular con Espirales contra Aneurismas Cerebrales

GPIs Superior for Rescue Treatment after Endovascular Coiling for Cerebral Aneurysm

La Bivalirudina Mejora a la Heprina en la Reducción del Riesgo Hemorrágico tras la CAS

Bivalirudin Bests Heparin for Lowering Bleeding Risk After CAS

Vorapaxar Substudy Shows Broad MI Reduction in High-Risk ACS Patients

Un Subestudio del Vorapaxar revela un Amplio Descenso de IM en Pacientes SCA de Alto Riesgo

Rivaroxaban Added to Dual Antiplatelet Therapy Cuts Stent Thrombosis in ACS Patients

Rivaroxaban + Terapia Antiplaquetaria Doble Reducen la Trombosis del Stent en Pacientes víctimas de un SCA

Reduction of Stent Thrombosis in ACS Patients Treated with Rivaroxaban in ATLAS ACS 2-TIMI 51

SCAAR Turns 20: PCI Expanded to Higher-Risk Patients with No Mortality Trade-off

SCAAR Cumple 20 Años: PCI Ampliada a Pacientes de Mayor Rieso sin Compensación de Mortalidad

STREAM: Fibrinolysis Strategy Effective for STEMI Patients Far From PCI Hospital

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content